Stocks in news: JSW Energy, IDFC First Bank, Zydus Life, Alkem Labs, Tata Elxsi

JSW Energy's board to meet on April 2 to consider a proposal for raising of funds through the issuance of eligible securities of the company by way of private offerings or on a preferential allotment basis.

Indian markets showed strength amid mixed global cues and gained over half a percent on Wednesday. In today's trade, shares of , , , , among others will be in focus due to various news developments.

JSW Energy
JSW Energy's board to meet on April 2 to consider a proposal for raising of funds through the issuance of eligible securities of the company by way of private offerings or on a preferential allotment basis.

CDSL
Standard Chartered Bank has sold its entire stake and exited Central Depository Services (India) Ltd through bulk deals on Wednesday.

IDFC First Bank
Private equity major Warburg Pincus is likely to exit IDFC First Bank by selling its entire 2.3% stake in the lender through block deals on Thursday, according to reports.

Zydus Life
Zydus Lifesciences said the US health regulator has issued a Form-483 with four observations following the inspection of its Ahmedabad-based SEZ Onco Injectable manufacturing plant.

Bank of Maharashtra
The union government has appointed Nidhu Saxena as Managing Director and Chief Executive Officer of Bank of Maharashtra.

Alkem Labs
USFDA had conducted an inspection at the company' Baddi manufacturing facility and issued Form 483 with 10 observations.


Emami has entered into a share purchase agreement with the founder and other shareholders of Brillare for acquiring the remaining stake of 4.64% of that company.

Tata Elxsi
Tata Elxsi has partnered with Drager to advance critical care innovation in India. Under the partnership, Drager will establish its offshore development center (ODC) at Tata Elxsi's facility in Pune.

Chalet Hotels
Chalet Hotels has launched a qualified institutional placement (QIP) issue to raise up to Rs 1,200 crore. The floor price is set at Rs 775 per share.

Dr Reddy’s
Dr Reddy’s has signed an exclusive distribution agreement with Sanofi Healthcare India to promote and distribute the vaccine brands of the company.

Source: Stocks-Markets-Economic Times

Publicații recente
Sweden picks Embraer's C-390 as new military cargo aircraft
10.11.2024 - 02:00
Exclusive-US ordered TSMC to halt shipments to China of chips used in AI applications, source says
10.11.2024 - 02:00
UMG says Pershing does not have right to require Amsterdam delisting
09.11.2024 - 20:00
Here's how Rosenblatt thinks Trump's win could impact these internet media stocks
09.11.2024 - 12:00
M&A deal activity has accelerated in 2024
09.11.2024 - 12:00
Booking.com could cut jobs as part of reorganization plan
09.11.2024 - 12:00
5 ways Trump will change AI according to Deutsche Bank
09.11.2024 - 11:00
How much can asset sales help Boeing?
09.11.2024 - 11:00
Exclusive-Toyota aims to ramp up China production in a strategy pivot, sources say
09.11.2024 - 11:00
Is QT a threat to markets?
09.11.2024 - 11:00
BofA unpacks potential impact of US election on Consumer Finance stocks
09.11.2024 - 11:00
Morgan Stanley breaks down the overlap between Walmart, Amazon, Costco memberships
09.11.2024 - 11:00
Exclusive-Singapore's DBS eyes Malaysian bank stakes in expansion push, sources say
09.11.2024 - 06:00
Firefighters gaining control over devastating wildfire near Los Angeles
09.11.2024 - 05:00
OpenAI's ChatGPT back up after brief outage
09.11.2024 - 04:00

© Analytic DC. All Rights Reserved.

new
Analiza pieței Cum va afecta raportul NFP de mâine cursul de schimb al dolarului american?